BiP (GRP78)

BiP (GRP78)

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">BiP (GRP78)</th>
</tr>
<tr>
<td class="label">Molecule</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">[IRE1](/proteins/ire1)</td>
<td>Regulates activation</td>
</tr>
<tr>
<td class="label">PERK</td>
<td>Regulates activation</td>
</tr>
<tr>
<td class="label">ATF6</td>
<td>Regulates activation</td>
</tr>
<tr>
<td class="label">[Calreticulin](/proteins/calreticulin-protein)</td>
<td>Collaborates in ER</td>
</tr>
<tr>
<td class="label">Protein disulfide isomerase</td>
<td>Collaborates</td>
</tr>
<tr>
<td class="label">Derlins</td>
<td>Retrotranslocation</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/anxiety" style="color:#ef9a9a">Anxiety</a>, <a href="/wiki/bipolar" style="color:#ef9a9a">Bipolar</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">160 edges</a></td>
</tr>
</table>

BiP is a protein. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target.

BiP (GRP78)

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">BiP (GRP78)</th>
</tr>
<tr>
<td class="label">Molecule</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">[IRE1](/proteins/ire1)</td>
<td>Regulates activation</td>
</tr>
<tr>
<td class="label">PERK</td>
<td>Regulates activation</td>
</tr>
<tr>
<td class="label">ATF6</td>
<td>Regulates activation</td>
</tr>
<tr>
<td class="label">[Calreticulin](/proteins/calreticulin-protein)</td>
<td>Collaborates in ER</td>
</tr>
<tr>
<td class="label">Protein disulfide isomerase</td>
<td>Collaborates</td>
</tr>
<tr>
<td class="label">Derlins</td>
<td>Retrotranslocation</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/anxiety" style="color:#ef9a9a">Anxiety</a>, <a href="/wiki/bipolar" style="color:#ef9a9a">Bipolar</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">160 edges</a></td>
</tr>
</table>

BiP is a protein. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target.

Binding immunoglobulin protein (BiP), also known as glucose-regulated protein 78 (GRP78) or HSPA5, is a master endoplasmic reticulum (ER) chaperone and central regulator of the [unfolded protein response](/entities/unfolded-protein-response) (UPR). BiP is essential for protein folding, calcium binding, and ER stress signaling, playing critical roles in neurodegeneration where ER stress is a prominent feature.

Structure and Function

Molecular Architecture

BiP is a 70-kDa heat shock protein family member consisting of[@haas1983]:

• Nucleotide-binding domain (NBD): Binds and hydrolyzes ATP
• Substrate-binding domain (SBD): Interacts with unfolded proteins
• Lid domain: Covers the SBD in the ATP-bound state
• C-terminal ER retention signal (KDEL): Maintains ER localization

Chaperone Mechanism

BiP functions through an ATP-dependent chaperone cycle[@mayer2005]:

Unfolded Protein Response (UPR)

BiP is the master regulator of the UPR[@bertolotti2000]:

• Basal state: BiP binds to ER stress sensors (IRE1, PERK, ATF6), keeping them inactive
• ER stress: Unfolded proteins compete for BiP binding
• Sensor activation: Released sensors initiate UPR signaling
• Adaptive response: Increased chaperone production and protein degradation

Role in Neurodegeneration

ER Stress in Neurodegeneration

ER stress is a hallmark of neurodegenerative diseases[@scheper2015]:

• Accumulation of misfolded proteins ([Aβ](/proteins/amyloid-beta), [tau](/proteins/tau), α-synuclein)
• Chronic UPR activation
• BiP induction as compensatory response
• Transition from protective to apoptotic signaling

Alzheimer's Disease

In [Alzheimer's disease](/diseases/alzheimers-disease), BiP plays complex roles[@hoozemans2007]:

• Upregulated in affected brain regions
• Interacts with [amyloid precursor protein](/entities/app-protein) (APP)
• May modulate Aβ production
• Chronic ER stress overwhelms chaperone capacity

BiP and Tau Pathology

BiP interacts with [tau](/proteins/tau)[@gupta2021]:

• Binds misfolded tau species
• May prevent tau aggregation
• UPR activation in tauopathy models
• Potential therapeutic target

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease)[@smith2020]:

• BiP upregulation in dopaminergic [neurons](/entities/neurons)
• [α-Synuclein](/proteins/alpha-synuclein) accumulation induces ER stress
• BiP may protect against α-synuclein toxicity
• PERK/ATF4 pathway activation

Amyotrophic Lateral Sclerosis

In [ALS](/diseases/amyotrophic-lateral-sclerosis)[@ilieva2007]:

• Mutant SOD1 aggregates induce ER stress
• BiP levels increase as protective response
• [TDP-43](/mechanisms/tdp-43-proteinopathy) pathology associated with UPR activation
• Chaperone-based therapeutic approaches

Prion Diseases

In prion diseases[@hetz2003]:

• Prion protein misfolding triggers ER stress
• BiP expression correlates with disease stage
• UPR mediates neurotoxicity
• Target for therapeutic intervention

UPR Sensor Regulation

BiP binds to and regulates three UPR sensors[@walter2011]:

IRE1 (ERN1)

[BiP binds to the luminal domain of IRE1](/proteins/ire1):

• ER stress releases BiP from IRE1
• IRE1 dimerizes and autophosphorylates
• Initiates XBP1 splicing pathway
• Activates JNK and inflammatory responses

PERK (EIF2AK3)

BiP binding keeps PERK inactive:

• Stress releases PERK
• PERK phosphorylates eIF2α
• Reduces general translation, increases ATF4
• Activates [autophagy](/entities/autophagy) and antioxidant responses

ATF6

BiP binding retains ATF6 in the ER:

• Stress releases ATF6
• ATF6 translocates to Golgi for cleavage
• Cleaved ATF6 acts as transcription factor
• Induces chaperones including BiP itself

Therapeutic Implications

BiP Enhancers

Strategies to boost BiP activity[@gupta2021a]:

• Chemical chaperones: 4-phenylbutyrate, tauroursodeoxycholic acid (TUDCA)
• Gene therapy: BiP overexpression in animal models
• Small molecule activators: Modulating ATPase cycle
• ER proteostasis regulators: BIX compounds

UPR Modulation

Targeting UPR pathways[@wang2014]:

• PERK inhibitors: GSK2606414, GSK2656157
• IRE1 modulators: Kinase inhibitors, RNase modulators
• ATF6 activators: Enhanced chaperone production
• Balancing protection vs. [apoptosis](/entities/apoptosis)

Chemical Chaperones in Clinical Use

Several chemical chaperones are in clinical trials[@lee2019]:

• TUDCA: [Bile acid with chaperone activity](/therapeutics/tudca-udca-neurodegeneration)
• 4-PBA: FDA-approved for urea cycle disorders
• Potential applications: Neurodegenerative disease trials

BiP as a Biomarker

Diagnostic Potential

BiP levels may indicate ER stress status[@lajoie2019]:

• Increased CSF BiP in neurodegeneration
• Correlation with disease progression
• May predict response to therapy
• Blood levels reflect systemic ER stress

Research Applications

BiP reporters are used in research[@samali2008]:

• Fluorescent BiP fusion proteins
• ER stress sensors
• Drug screening platforms
• Disease model characterization

Interaction with Other Molecules

Research Directions

Current research focuses on:

See Also

• [Alzheimer's disease](/diseases/alzheimers-disease)
• [Parkinson's disease](/diseases/parkinsons-disease)
• [ALS](/diseases/amyotrophic-lateral-sclerosis)

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
• [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)

References